Apyx Medical (APYX) Projected to Post Earnings on Thursday

Key Points

• Apyx Medical is set to release its Q2 2025 earnings on August 7th, with analysts expecting a loss of ($0.09) per share and revenue of $11.69 million.
• The company recently reported a negative return on equity of 156.85% and a net margin of 42.37% in its last quarterly earnings, indicating financial challenges.
• Apyx Medical's shares opened at $1.90 and have fluctuated between a 1-year low of $0.76 and a high of $2.73.

Apyx Medical (NASDAQ:APYX - Get Free Report) is projected to issue its Q2 2025 quarterly earnings data after the market closes on Thursday, August 7th. Analysts expect the company to announce earnings of ($0.09) per share and revenue of $11.69 million for the quarter. Apyx Medical has set its FY 2025 guidance at EPS.

Apyx Medical (NASDAQ:APYX - Get Free Report) last released its quarterly earnings results on Thursday, May 8th. The company reported ($0.10) EPS for the quarter, beating the consensus estimate of ($0.13) by $0.03. The company had revenue of $9.43 million for the quarter, compared to analyst estimates of $9.39 million. Apyx Medical had a negative net margin of 42.37% and a negative return on equity of 156.85%. On average, analysts expect Apyx Medical to post $-1 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Apyx Medical Stock Performance

APYX stock traded up $0.08 during midday trading on Monday, hitting $1.83. 28,007 shares of the stock traded hands, compared to its average volume of 116,693. The firm has a market cap of $68.97 million, a P/E ratio of -3.32 and a beta of 1.39. The company has a debt-to-equity ratio of 3.21, a current ratio of 5.45 and a quick ratio of 4.64. The stock's fifty day simple moving average is $1.99 and its 200-day simple moving average is $1.51. Apyx Medical has a 1-year low of $0.76 and a 1-year high of $2.73.

About Apyx Medical

Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures.